New 'trolls' are crushing innovation in biopharma
July 22, 2015 at 10:16 AM EDT
Hedge funds and and a new type of patent troll are using loopholes in patent law for gains, stifling innovation, says author Joseph Gulfo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|